Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007
Endothelin-a receptor antagonists reduce eNOS gene expression in rats with chronic hypoxic pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 271s Year: 2003
Looking to the future: a new decade of pulmonary arterial hypertension therapy Source: Eur Respir Rev 2011; 20: 262-269 Year: 2011
Effects of endothelial nitric oxide synthase enzyme, angiotensin converting enzyme and serotonin transporter genotypes on pulmonary hypertension in COPD Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010
Upregulation of endothelial nitric oxide synthase in pulmonary artery of infants with pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 694s Year: 2004
Increased nitric oxide synthase isoforms, endothelin 1 and apoptosis varied in lungs from patients with (SSc) and had impact on pulmonary function tests Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Effect of the Asp298 variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006
Differential action of beraprost isomers on prostacyclin (IP) receptors and PPARβ in pulmonary arteries Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015
Combination of inhaled nitric oxide and an endothelinA -receptor antagonist in acute pulmonary thromboembolism Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003
Effects of oral tolerance on neuronal nitric oxidase synthase expression on bronchial epithelial cells in a model of chronic pulmonary inflammation Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
Increased expression of inducible nitric oxide synthase (iNOS) in peripheral lung of severe COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment Source: Eur Respir J 2011; 38: 851-860 Year: 2011
Reduce expression of endothelial nitric oxide synthase lead to more severe pulmonary complex vascular lesions associated with HIV Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018
Expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) in pulmonary arteries of patients with severe COPD Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation Year: 2003
Effects of AT1 receptor blockade on pulmonary and systemic manifestations in a COPD/emphysema mouse model Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009
The role of inducible NO synthase (iNOS) in a cell model of steroid resistance in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Inducible nitric oxide synthase inhibition reduces eosinophilic and lymphocytic recruitment to lung parenchyma in guinea pigs with chronic pulmonary inflammation Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007
NTP42, an antagonist of the thromboxane receptor, attenuates experimentally-induced pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019
Protective role of nitric oxide synthases in pulmonary emphysema in mice Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019
Inhaled nitric oxide decreases pulmonary endothelial nitric oxide synthase expression and activity in normal newborn rat lungs Source: ERJ Open Res 2016 Year: 2016